Wright Medical Group

What Wright Medical Group does

Wright Medical Group was an international medical device company specializing in extremities and biologics. Headquartered in Arlington, United States, with between 1,001 and 5,000 employees, the company was founded in 1950 by Frank O. Wright and, prior to delisting, traded on NASDAQ under the symbol WMGI. Its product portfolio focused on upper-extremity (shoulder, elbow, hand, wrist) and lower-extremity (foot and ankle) implants and instruments, alongside biologic products supporting orthopedic healing. Over a multi-decade history it executed a sustained M&A program — including BioMimetic Therapeutics (2012, $190M), Biotech International (2013), Solana Surgical (2014, $90M), OrthoPro (2014), Imascap (2017, $88.8M), and Cartiva (2018, $435M) — that broadened the portfolio into cartilage repair, biologics, and software-assisted surgical planning.

The underlying business model combined regulated medical-device sales (implants, instruments, and biologics) into hospitals, ambulatory surgery centers, and surgical specialists, with international distribution supporting customer reach beyond the United States. Revenue was generated through product sales to healthcare providers under medical-device procurement and reimbursement frameworks; pricing was not disclosed in the supplied materials. In 2018, the company raised $675M of additional financing, with a portion visibly funding the Cartiva transaction, reinforcing an acquisition-led growth posture.

The company's standalone operating posture ended after delisting from NASDAQ; based on available data, the entity no longer trades as an independent issuer. Leadership at the time included Robert J. Palmisano as President & CEO.

Name

Wright Medical Group

Website

https://wright.com

Company type

Private

Founded year

1950

Headcount range

1,001–5,000 employees

Short description

Wright Medical Group is an international medical device company founded in 1950 and headquartered in Arlington, United States, specializing in extremities (upper and lower) and biologics implants sold to hospitals, ambulatory surgery centers, and orthopedic surgeons worldwide.

Ownership category

akta.pro rank

Product category

Orthopedic Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Orthopedic Trauma & Extremities Fixation (Plates/Screws/Nails/External Fixation) (HLAHAEAB)

akta.pro secondary industry

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

Keywords

• Orthopedic medical devices
• Extremity implants
• Biologics products
• Foot ankle surgery
• Upper extremity devices

Headquarters

HQ city

Arlington

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Core offering

Wright Medical Group designs, manufactures, and markets orthopedic medical devices focused on extremities (foot, ankle, hand, wrist, elbow, shoulder) and biologics for bone and soft-tissue repair. The company sells implants, instruments, and regenerative biologic products used by orthopedic surgeons in hospitals and surgical centers globally.

Product overview

No product information for Wright Medical Group found in the provided sources. The source data contains market reports and competitor information for companies including Stryker, Zimmer Biomet, Smith & Nephew, Enovis Corporation, and others in the orthopedic medical device space.

Differentiator

Problem solved

Functional benefit

Products and services

• Extremity implants (upper and lower)

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Zimmer Biomet: One of the largest orthopedic device companies in the world, with significant extremities, trauma, and biologics franchises that overlap directly with Wright's product portfolio. Zimmer Biomet competes in shoulder/elbow reconstruction and foot/ankle, and serves the same hospital and ambulatory surgery center customers.
• Stryker: Global orthopedic medical device leader that ultimately acquired Wright Medical Group in 2020. Stryker has a large extremities and trauma portfolio that directly overlaps with Wright's core offerings, including foot/ankle and upper extremities, and competes head-to-head across hospital channels.
• DePuy Synthes (Johnson & Johnson MedTech): Johnson & Johnson's orthopedic and trauma division, offering shoulder/elbow arthroplasty, foot/ankle, and trauma fixation products that overlap with Wright's extremities and biologics portfolio. Competes in the same hospital purchasing channels with greater scale and a broader portfolio.
• Smith & Nephew: Global medical device company with a substantial orthopedics business including shoulder, elbow, foot/ankle reconstruction and trauma products that compete directly with Wright's extremities portfolio. Comparable in being a multi-segment orthopedic incumbent with biologics and sports medicine adjacencies.

Direct peers

• Exactech: Orthopedic device company specializing in joint replacement implants, including shoulder, ankle, and extremities, as well as bone graft substitutes. Direct competitor to Wright in extremities joint reconstruction and biologics, with comparable end-customer focus on orthopedic surgeons.
• Integra LifeSciences: Medical technology company with extremities, orthopedics, and tissue technologies (biologics/wound care) segments. Competitor in upper-extremity and foot/ankle reconstruction as well as in the biologics adjacencies where Wright also participated.
• Acumed: Orthopedic implant company focused on upper and lower extremity fracture fixation and reconstruction. Directly comparable to Wright's extremities fixation and trauma business, serving similar hand, wrist, foot, and ankle surgeons.
• Paragon 28: Pure-play foot and ankle orthopedic company offering specialty implants, plates, screws, and biologics targeted specifically at foot and ankle surgeons. Highly comparable to Wright's lower-extremity franchise and represents one of the closest specialty-focused competitors.
• Arthrex: Privately held medical device company focused on extremities, sports medicine, and orthopedic soft tissue repair, with a particularly strong foot/ankle and upper-extremity portfolio. Highly comparable to Wright as a specialist in extremities and biologics serving the same surgeon customer base.

Emerging players

• Treace Medical Concepts: Emerging foot and ankle orthopedic company focused on bunion correction (Lapiplasty procedure) with a targeted implant and instrumentation system. Comparable to Wright's foot and ankle franchise as a specialist addressing a high-volume foot indication with a differentiated procedural technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks3 records

Key highlights7 records

Customer concentration

• Xx.com/wrightmedtech
• Facebookfacebook.com/301779626647076
• LinkedInlinkedin.com/company/wright-medical-technology

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A7 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wright Medical Group